Astrazeneca Share News (AZN)

LONDON BROKER RATINGS: Goldman Sachs cuts Relx but raises WPP

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

LONDON BROKER RATINGS: Bank of America and Oddo BHF cut Whitbread

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

TOP NEWS: AstraZeneca completes acquisition of Neogene Therapeutics

(Alliance News) - AstraZeneca PLC on Monday said it completed its acquisition of Neogene Therapeutics Inc, a clinical-stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies.

LONDON BRIEFING: FTSE 100 seen flat; Just Eat and Sainsbury's partner

(Alliance News) - With US financial markets closed for a public holiday on Monday and after better-than-expected data for the UK economy on Friday, stocks in London were set to start the week slightly higher.

UK FTSE 100 at highest since May 2018, boosted by economic data

UK economy unexpectedly grew in November

*

CORRECT: AstraZeneca asthma drug okayed in EU for self-administration

(Correcting headline to refer to EU.)

AstraZeneca asthma drug approved in US for self-administration

(Alliance News) - AstraZeneca PLC on Friday said Tezspire has been approved for self-administration in the EU in a new pre-filled pen, for severe asthma patients aged 12 years and older.

TOP NEWS: FDA approves AstraZeneca asthma drug Airsupra for adults

(Alliance News) - AstraZeneca PLC on Wednesday said the US Food & Drug Administration approved its asthma drug Airsupra for adults.

C4X Discovery promotes Nick Ray to chief scientific officer

(Alliance News) - C4X Discovery Holdings PLC on Tuesday said it appointed a new scientific officer, promoting internally.

European shares rise on China reopening optimism, tech stocks lead gains

Rate-sensitive tech stocks boost STOXX 600

*

AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal

AZN shares slip 1% on Monday

*

Terminal rate repricing might not be over

STOXX 600 up 0.4%

*

TOP NEWS: AstraZeneca buys biotech CinCor for up to USD1.8 billion

(Alliance News) - AstraZeneca PLC on Monday said it has acquired CinCor Pharma Inc for an upfront cash consideration of around USD1.3 billion, though the fee could rise to USD1.8 billion.

Europe set to extend new year rally

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

LONDON BRIEFING: Astra makes USD1.8 billion buy; Keller hit by fraud

(Alliance News) - London's FTSE 100 was called to start the new week higher, after a strong handover from Asia on Monday and a bullish end to the first week of the year in New York.